The company shall acquire a further 34 percent stake at Rs 155 crore
The three private equity firms are eyeing the 60.41 percent controlling stake in the cancer hospital chain, currently held by CVC Capital.
The healthcare player had made important strides in expanding its regional network with acquisitions in Indore and Nagpur
Net Sales are expected to increase by 16.1 percent Y-o-Y (up 2.9 percent Q-o-Q) to Rs. 375.1 crore, according to ICICI Direct.
With the transaction, HCG has increased its holding in Suchirayu from the existing 17.7 per cent to 78.6 per cent, the company said in a statement.
Shares of Healthcare Global Enterprises, the cancer-care network operator, started off trade on a negative note despite positive market trend.
The Rs 650-crore IPO of cancer- care network operator HealthCare Global Enterprises was oversubscribed 1.56 times on the last day of the offer today.
SPA Research has come out with its report on Healthcare Global IPO. The research firm has recommended to "SUBSCRIBE" the IPO with Cautions in its research report as on March 15, 2016.
HEM securities has come out with its report on Healthcare Global IPO. The research firm has recommended to "AVOID" the IPO with Cautions in its research report as on March 15, 2016.
Experts believe the timing is apt – the market in a bull run and many private equity players that have invested in these companies are looking for an exit. Hence, through these IPOs, these PE players will have an easier exit route.